NEW YORK (GenomeWeb News) – MolecularHealth today announced an agreement under which GATC Biotech will provide its laboratory information management system in MolecularHealth's new clinical laboratory.

GATC also will provide protocols, support, and training to MolecularHealth's staff. The deal, MolecularHealth said, will complement its next-generation sequencing offerings and its TreatmentMap oncology treatment decision support platform, which is anticipated to launch in the current quarter.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: swapping yeast genes with human orthologs to study conservation of function, and more.

Hong Kong is using DNA phenotyping to shame litterers.

A study appearing in Cell suggests some metastatic castration-resistant prostate cancer patients could benefit from PARP inhibitor therapy.

NIH's Francis Collins writes that scientific advances are poised to help populations all over the world, but more scientists are needed to keep the momentum.